Immunology and Bi...
Follow
Find
5.1K views | +9 today
Immunology and Biotherapies
Page Ressources et Actualités du DIU immunologie et biothérapies
Your new post is loading...
Your new post is loading...
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Drug Leads to Lasting Response in Crohn's - MedPage Today

Drug Leads to Lasting Response in Crohn'sMedPage TodayLAS VEGAS -- Patients with treatment-refractory Crohn's disease obtained long-term improvement when treated with the investigational agent vedolizumab, which selectively targets lymphocytes in...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Antibodies powerhouse to raise more millions - Business Weekly

Antibodies powerhouse to raise more millions - Business Weekly | Immunology and Biotherapies | Scoop.it
Antibodies powerhouse to raise more millionsBusiness WeeklyFor all its power as Europe's top BioMedTech cluster, Cambridge has to date only triggered one blockbuster drug – Humira, which was based on Cambridge Antibody Technology's IP.
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Targeted cancer drugs are not living up to expectations, say experts

Targeted cancer drugs are not living up to expectations, say experts | Immunology and Biotherapies | Scoop.it
Cancer specialists say drugs that were hailed as breakthroughs a few years ago have proved disappointing (Failure of targeted therapies for #cancer.)...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

New Developments In Lipids To Watch Closely - Seeking Alpha

New Developments In Lipids To Watch Closely - Seeking Alpha | Immunology and Biotherapies | Scoop.it
Lpath (LPTN) is engaged in the discovery and development of monoclonal antibodies that neutralize bioactive lipids. The study of lipids (called lipidomics) is a growing field of research that has already identified dozens of ...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

ViaCyte Awarded Funds for Implantable Diabetes Cell Therapy - Genetic Engineering News

ViaCyte Awarded Funds for Implantable Diabetes Cell Therapy - Genetic Engineering News | Immunology and Biotherapies | Scoop.it
89.3 KPCCViaCyte Awarded Funds for Implantable Diabetes Cell TherapyGenetic Engineering NewsViaCyte was awarded a $10.1 million Strategic Partnership Award from the California Institute of Regenerative Medicine (CIRM) to support IND filing and...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Robust Sipuleucel-T Immune Activity Is Detailed in Pooled Data Analysis - OncLive

Robust Sipuleucel-T Immune Activity Is Detailed in Pooled Data Analysis - OncLive | Immunology and Biotherapies | Scoop.it
OncLiveRobust Sipuleucel-T Immune Activity Is Detailed in Pooled Data AnalysisOncLiveSipuleucel-T is created by culturing a patient's own isolated peripheral blood mononuclear cells, including antigenpresenting cells (APCs).
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Antibody Responses to Routine Pediatric Vaccines Administere... : The Pediatric Infectious Disease Journal

Background: A 13-valent pneumococcal conjugate vaccine (PCV13) has been licensed in more than 100 countries to broaden coverage against pneumococcal disease.
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Chinese Clinical Trial Register (ChiCTR) - The world health organization international clinical trials registered organization registered platform

Chinese Clinical Trial Register (ChiCTR) - The world health organization international clinical trials registered organization registered platform | Immunology and Biotherapies | Scoop.it
Auto- BM mononuclear cells versus mesenchymal stromal cells in cerebral palsy (A) (China) http://t.co/cqWdZglC...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

BTS and RA Joint Congress

Abstract submission now open for the British Transplantation Society/Renal Association 2013 conference.
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Theraclone Sciences begins phase II viral challenge study of therapeutic ... - pharmabiz.com

Theraclone Sciences begins phase II viral challenge study of therapeutic ... - pharmabiz.com | Immunology and Biotherapies | Scoop.it
Theraclone Sciences begins phase II viral challenge study of therapeutic ...pharmabiz.comTheraclone Sciences, Inc., a therapeutic antibody discovery and development company, has started phase II clinical study of TCN-032 in a viral challenge model.
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

BMC Cardiovascular Disorders | Abstract | Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation

Circulating endothelial progenitor cell (EPC) capture technology improves endothelialization rates of Sirolimus-eluting stents (SESs), but its long-term consequences are unknown, as demonstrated by the occurrence of late in-stent thrombosis, even...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR) | Clinical Trials News Digest

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR) | Clinical Trials News Digest | Immunology and Biotherapies | Scoop.it
Condition : Acute Myeloid Leukemia Interventions : Drug: IPH2102 at 0.1 mg/kg; Drug: IPH2102 at 1 mg/kg; Drug: Placebo (normal saline solution) Sponsors : Innate Pharma; Innate Pharma Active, not recruiting - verified October 2012 (Efficacy Study ...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

South Korea Okays First Officially Approved Monoclonal Antibody for RA :: Article - The Rheumatologist

South Korea Okays First Officially Approved Monoclonal Antibody for RA :: Article - The Rheumatologist | Immunology and Biotherapies | Scoop.it
In early August, the South Korean Food and Drug Administration approved marketing of Celltrionrsquos Remsima, a medication that is a biosimilar to Johnson and Johnsonrsquos Remicade infliximab.
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Biosimilar versions of MAbs for cancer forecast to garner sales of $4.9 ... - The Pharma Letter

Biosimilar versions of MAbs for cancer forecast to garner sales of $4.9 ... - The Pharma Letter | Immunology and Biotherapies | Scoop.it
Biosimilar versions of MAbs for cancer forecast to garner sales of $4.9 ...The Pharma LetterWhile branded versions of monoclonal antibodies for cancer are expected to maintain sales of $6.7 million across the USA, the EU5 countries (France,...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

GSK starts final-stage tests on severe asthma drug - Reuters

GSK starts final-stage tests on severe asthma drug - Reuters | Immunology and Biotherapies | Scoop.it
GSK starts final-stage tests on severe asthma drugReutersThe move to progress the injectable antibody treatment mepolizumab into Phase III trials had been expected after an earlier study showed it nearly halved the number of attacks suffered by...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Adult immunizations: updates and ... [Ann Allergy Asthma Immunol. 2012] - PubMed - NCBI

PubMed comprises more than 22 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Oncology News - Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20+ diffuse large B-cell lymphoma: Final analysis of The Collaborative Trial in ...

Oncology News - Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20+ diffuse large B-cell lymphoma: Final analysis of The Collaborative Trial in ... | Immunology and Biotherapies | Scoop.it
Oncology Medical Article: Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20+ diffuse large B-cell lymphoma: Final analysis of The Collaborative Trial in Relapsed Aggressive Lymphoma (Rituximab ...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

medicine - When did the first organ transplantation operation occurr? - History Beta - Stack Exchange

When did the first organ transplantation operation occurr?
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Targeting the MAGE A3 antigen in pancreatic cancer.

Related Articles Targeting the MAGE A3 antigen in pancreatic cancer. Surgery. 2012 Sep;152(3 Suppl 1):S13-8 Authors: Cogdill AP, Frederick DT, Cooper ZA, Garber HR, Ferrone CR, Fiedler A, Rosenberg L, Thayer SP, Warshaw AL, Wargo ...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Symposier - An RNA Aptamer That Binds Carcinoembryonic Antigen Inhibits

Symposier - An RNA Aptamer That Binds Carcinoembryonic Antigen Inhibits | Immunology and Biotherapies | Scoop.it
Uploaded and shared in Youtube by: AmerGastroAssn — Dr.
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Bone marrow transplantation improves the outco... [Hum Mol Genet. 2012] - PubMed - NCBI

PubMed comprises more than 22 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

GPs lack 'detailed knowledge' on donation and transplantation ...

GPs lack 'detailed knowledge' on donation and transplantation ... | Immunology and Biotherapies | Scoop.it
By Lloyd Mudiwa. There is a lack of “detailed knowledge” on organ donation and transplantation in general practice, which may be reflective of the entire population, researchers at St Vincent's University Hospital have said.
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Novartis Cannibalizes Gleevec to Boost New Cancer Drug

Novartis Cannibalizes Gleevec to Boost New Cancer Drug | Immunology and Biotherapies | Scoop.it
Novartis AG wants patients to stop taking one of its best-selling drugs.
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Download: Article on production and purification of an antibody therapeutic

Download: Article on production and purification of an antibody therapeutic | Immunology and Biotherapies | Scoop.it
Michiel Ultee, Chief Scientific Officer at Laureate Biopharmaceutical Services, kindly provided this article entitled, ‘Production and Purification of a PER.C6-Expressed IgM Antibody Therapeutic.’ Download the [...] (Interesting article by Laureate...
more...
No comment yet.
Scooped by Gilbert Faure au nom de l'ASSIM
Scoop.it!

Diabetes stem cell therapy moving toward clinical trials

Diabetes stem cell therapy moving toward clinical trials | Immunology and Biotherapies | Scoop.it
The ICOC approved funding for a ViaCyte stem cell therapy for type 1 diabetes as part of our new Strategic Partnership Award initiative. This initiative is an effort to attract more engagement and investment from industry in ...
more...
No comment yet.